![John D. Thompson](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John D. Thompson
Directeur/Membre du Conseil chez Molecular Transfer, Inc.
Relations actives
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Daniel Komarek | M | - |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
Joel Jesse | M | - |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
William Snider | M | 54 |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
David M. Manyak | M | 71 |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
Derek Woods | M | - |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
Sisi Gallagher | F | - |
Molecular Transfer, Inc.
![]() Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | - |
Graphique Relationnel
Relation dans plusieurs entreprises
Anciennes relations
Nom | Sexe | Age | Sociétés liées | Collaboration |
---|---|---|---|---|
Mark P. Colonnese | M | 68 |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 2 ans |
Antonius P. Schuh | M | 59 |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 5 ans |
Rodney Markin | M | 67 |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 7 ans |
Mya Thomae | F | - |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | 2 ans |
Harjit Kullar | M | - |
Transgenomic, Inc.
![]() Transgenomic, Inc. Medical SpecialtiesHealth Technology Transgenomic, Inc. is a global biotechnology company, which provides personalized medicine in the detection and treatment of cancer and inherited diseases through its proprietary molecular technologies and world-class clinical and research services. It operates through the following reportable segments: Laboratory Services and Genetic Assays and Platforms. The Laboratory Services segment is a combination of clinical laboratories and pharmacogenomic services business segments. The Clinical Laboratories segment specializes in genetic testing for cardiology, neurology, mitochondrial disorders and oncology. The Laboratory Services segment also provides pharmacogenomics research services supporting Phase II and Phase III clinical trials conducted by pharmaceutical companies and it employs a variety of genomic testing service technologies, including ICE COLD-PCR technology.The Genetic Assay and Platforms segment includes WAVE System product, which has broad applicability to genetic variation detection in both molecular genetic research and molecular diagnostics. This segment also manufactures and sells consumable products that can be used on multiple, independent platforms. These products include SURVEYOR Nuclease and a range of chromatography columns. Transgenomic was founded on March 6, 1997 and is headquartered in Omaha, NE. | - |
Statistiques
Pays | Relations | % du total |
---|---|---|
Etats-Unis | 11 | 100,00% |
Age des relations
Actives
Passées
Homme
Femme
Administrateurs
Exécutifs
Provenance des relations
- Bourse
- Insiders
- John D. Thompson
- Réseau Personnel